Angelo Armandi
Impact in
- Hepatology top 2%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 93
- Liver Disease Diagnosis and Treatment 81
- Microscopic Colitis 9
- Hepatology 29
- Liver Disease and Transplantation 13
- Hepatitis C virus research 11
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Co-authors
- Elisabetta Bugianesi (59 shared papers)Gian Paolo Caviglia (58 shared papers)Chiara Rosso (45 shared papers)Davide Giuseppe Ribaldone (41 shared papers)Giorgio Maria Saracco (31 shared papers)Jörn Markus Schattenberg (13 shared papers)Marco Astegiano (8 shared papers)Antonella Olivero (15 shared papers)
In The Last Decade
Angelo Armandi
117 papers receiving 2.4k citations
Angelo Armandi's Hit Papers
Peers
Comparison fields: 5 of 101
- Hepatology 471
- Epidemiology 1.6k
- Endocrinology, Diabetes and Metabolism 375
- Physiology 228
- Pathology and Forensic Medicine 118
Countries citing papers authored by Angelo Armandi
This map shows the geographic impact of Angelo Armandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Armandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Armandi more than expected).
Fields of papers citing papers by Angelo Armandi
This network shows the impact of papers produced by Angelo Armandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Armandi. The network helps show where Angelo Armandi may publish in the future.
Co-authors
The 25 scholars most cited alongside Angelo Armandi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis Hit paper breakdown → | 2021 | 272 |
| 2 | 2021 | 171 | |
| 3 | Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease Hit paper breakdown → | 2024 | 166 |
| 4 | Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis Hit paper breakdown → | 2023 | 152 |
| 5 | 2021 | 140 | |
| 6 | An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) Hit paper breakdown → | 2024 | 138 |
| 7 | 2021 | 88 | |
| 8 | 2022 | 77 | |
| 9 | Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease Hit paper breakdown → | 2024 | 63 |
| 10 | 2023 | 55 | |
| 11 | 2024 | 45 | |
| 12 | 2023 | 44 | |
| 13 | Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment Hit paper breakdown → | 2025 | 42 |
| 14 | 2020 | 39 | |
| 15 | 2024 | 39 | |
| 16 | 2021 | 35 | |
| 17 | 2020 | 34 | |
| 18 | 2021 | 31 | |
| 19 | Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease Hit paper breakdown → | 2025 | 30 |
| 20 | 2021 | 29 |
About Angelo Armandi
Angelo Armandi is a scholar working on Epidemiology, Hepatology, Endocrinology, Diabetes and Metabolism, Genetics and Physiology, having authored 128 papers that have together received 2.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (81 papers), Inflammatory Bowel Disease (15 papers), Diet, Metabolism, and Disease (14 papers), Liver Disease and Transplantation (13 papers), Hepatitis C virus research (11 papers), Diet and metabolism studies (10 papers), Microscopic Colitis (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). The work is most often cited by research in Hepatology (471 citations), Epidemiology (1.6k citations), Endocrinology, Diabetes and Metabolism (375 citations), Physiology (228 citations) and Pathology and Forensic Medicine (118 citations). Angelo Armandi has collaborated with scholars based in Italy, Germany and Spain. Frequent co-authors include Elisabetta Bugianesi, Gian Paolo Caviglia, Chiara Rosso, Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Jörn Markus Schattenberg, Marco Astegiano, Antonella Olivero, Maria Lorena Abate and Rinaldo Pellicano. Their work appears in journals such as Journal of Clinical Medicine, Journal of Hepatology, Clinical Gastroenterology and Hepatology, Gut and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.